Reviva Pharmaceuticals Holdings, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 14.79 million shares for the 11-month period ending 2021-12-13, per its 10-K filed 2022-03-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-15
- Reviva Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 18.46M shares, a 565.04% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 12.87M shares, a 365.08% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 9.23M shares, a 233.47% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 3.93M shares, a 50.73% increase year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 3.06M shares.
- Reviva Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 2.61M shares.
- Reviva Pharmaceuticals Holdings, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 2.77M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 2 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 5 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 8 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 11 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|---|---|
| 2021-12-13 | 14.79M shares 10-K · filed 2022-03-15 | |||||||
| 2021-09-30 | 18.46M shares 10-Q · filed 2021-11-15 | 15.67M shares derived: average of 2 quarters · filed 2021-11-15 | 13.55M shares 10-Q · filed 2021-11-15 | 11.12M shares derived: average of 4 quarters · filed 2022-03-15 | ||||
| 2021-06-30 | 12.87M shares 10-Q · filed 2021-08-16 | 10.96M shares 10-Q · filed 2021-08-16 | 8.68M shares derived: average of 3 quarters · filed 2022-03-15 | |||||
| 2021-03-31 | 9.23M shares 10-Q · filed 2021-05-17 | 6.58M shares derived: average of 2 quarters · filed 2022-03-15 | ||||||
| 2020-12-31 | 3.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 3.06M shares 10-K · filed 2022-03-15 | ||||||
| 2020-11-30 | 2.81M shares 10-Q · filed 2021-01-14 | 2.75M shares 10-Q · filed 2021-01-14 | ||||||
| 2020-09-30 | 2.78M shares 10-Q · filed 2021-11-15 | 2.77M shares 10-Q · filed 2021-11-15 | ||||||
| 2020-08-31 | 2.74M shares 10-Q · filed 2020-10-14 | 2.72M shares 10-Q · filed 2020-10-14 | ||||||
| 2020-06-30 | 2.77M shares 10-Q · filed 2021-08-16 | 2.77M shares 10-Q · filed 2021-08-16 | ||||||
| 2020-05-31 | 2.70M shares 10-Q · filed 2020-07-07 | |||||||
| 2020-03-31 | 2.77M shares 10-Q · filed 2021-05-17 | |||||||
| 2020-02-29 | 2.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-04 | 2.62M shares derived: average of 2 quarters · filed 2021-01-14 | 2.61M shares derived: average of 3 quarters · filed 2021-01-14 | 2.61M shares 10-K · filed 2020-05-04 | ||||
| 2019-12-31 | 2.77M shares 10-K/A · filed 2021-05-07 | |||||||
| 2019-11-30 | 2.61M shares 10-Q · filed 2021-01-14 | 2.61M shares derived: average of 2 quarters · filed 2021-01-14 | 2.61M shares 10-Q · filed 2021-01-14 | |||||
| 2019-08-31 | 2.61M shares 10-Q · filed 2020-10-14 | 2.60M shares 10-Q · filed 2020-10-14 | ||||||
| 2019-05-31 | 2.60M shares 10-Q · filed 2020-07-07 | |||||||
| 2019-02-28 | 2.04M shares 10-K · filed 2020-05-04 | |||||||
| 2018-11-30 | 2.60M shares 10-Q · filed 2020-01-10 | 2.03M shares derived: average of 2 quarters · filed 2020-01-10 | 1.84M shares 10-Q · filed 2020-01-10 | |||||
| 2018-08-31 | 1.46M shares 10-Q · filed 2019-10-08 | 1.42M shares 10-Q · filed 2019-10-08 | ||||||
| 2018-05-31 | 1.38M shares 10-Q · filed 2019-07-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |